Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will present at three investment conferences during June 2012. Information regarding these conferences is provided below:
|Jefferies 2012 Global Healthcare Conference|
|New York, NY||Monday, June 4||3:30 p.m. ET|
|Goldman Sachs Global Healthcare Conference 2012|
|Long Beach, CA||Wednesday, June 6||5:00 p.m. ET|
|Wells Fargo Securities Health Care Conference|
|Boston, MA||Tuesday, June 19||1:30 p.m. ET|
Interested parties can access a live audio web cast of the presentation at http://www.salix.com. A replay of the presentation will be available at the same location.
Salix Pharmaceuticals, Ltd., headquartered in Raleigh, North Carolina, develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. Salix’s strategy is to in-license late-stage or marketed proprietary therapeutic drugs, complete any required development and regulatory submission of these products, and market them through the Company’s gastroenterology specialty sales and marketing team.